Zurex Pharma, a Madison biotech developing products aimed at preventing infections — in hospitals and at home — has raised $6.2 million in its first major funding round. Baird Venture Partners, Chicago, and the State of Wisconsin Investment Board led the financing. Read full Wisconsin State Journal story here.
Madison biotech Zurex Pharma gets $6.2 million funding boost
by Tech Council | May 22, 2012 | Featured, NEWSROOM, Tech Council News